|
000
| 01713cam 2200349zi 4500 |
|---|
| 001 | 9.909298 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107181856 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 220322t20222022onc o f00| 0 eng d |
|---|
| 020 | |a9780660426587 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH139-40/2022E-PDF |
|---|
| 245 | 00|aPOL-0004 : |bdrug good manufacturing practices (GMP) and drug establishment licence (DEL) enforcement policy. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2022. |
|---|
| 264 | 4|c©2022 |
|---|
| 300 | |a1 online resource (17 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: POL-0004 : Politique d'application de la loi pour les bonnes pratiques de fabrication (BPF) des médicaments et les licences d’établissement de produits pharmaceutiques (LEPP). |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 500 | |aReplaces: Good Manufacturing Practices (GMP) and Establishment Licensing Enforcement Directive, v3 (August 31, 2018). |
|---|
| 500 | |a"April 1, 2022." |
|---|
| 650 | 0|aDrug factories|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tPOL-0004 : |w(CaOODSP)9.909299 |
|---|
| 856 | 40|qPDF|s1.36 MB|uhttps://publications.gc.ca/collections/collection_2022/sc-hc/H139-40-2022-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/directives-guidance-documents-policies/drug-good-manufacturing-practices-establishment-licensing-enforcement-directive-0004.html |
|---|